147 results
Page 3 of 8
8-K
EX-10.1
9sv9y9q5t9y8w6iga
8 Sep 23
Entry into a Material Definitive Agreement
4:15pm
424B3
rf6h6ch8g
28 Jun 23
Prospectus supplement
4:56pm
424B3
4nru01
4 May 23
Prospectus supplement
4:30pm
8-K
EX-99.1
mln8n3sec4 qoc
17 Apr 23
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
4:06pm
8-K
EX-1.1
24chtdw 1s
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-4.3
8uty4sd0uha6ihm 1z
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-4.1
16mr0
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am